Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 1949 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

REVIEW ARTICLE

Safety of statins

Maji Debasish, Shaikh Shehla, Solanki Dharmesh, Gaurav Kumar

Year : 2013| Volume: 17| Issue : 4 | Page no: 636-646

   This article has been cited by
 
1 Effects of statins on mitochondrial pathways
Hamid Mollazadeh,Erfan Tavana,Giovanni Fanni,Simona Bo,Maciej Banach,Matteo Pirro,Stephan Haehling,Tannaz Jamialahmadi,Amirhossein Sahebkar
Journal of Cachexia, Sarcopenia and Muscle. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Liquid Crystalline Nanoparticles for Nasal Delivery of Rosuvastatin: Implications on Therapeutic Efficacy in Management of Epilepsy
Mohammad Zubair Ahmed,Urooj A. Khan,Abdul Haye,Nidhi B. Agarwal,Nabil A. Alhakamy,Hani A. Alhadrami,Musarrat Husain Warsi,Gaurav K. Jain
Pharmaceuticals. 2020; 13(11): 356
[Pubmed]  [Google Scholar] [DOI]
3 C2C12 cell model: its role in understanding of insulin resistance at the molecular level and pharmaceutical development at the preclinical stage
Chun Y. Wong,Hani Al-Salami,Crispin R. Dass
Journal of Pharmacy and Pharmacology. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Beyond lipid-lowering: role of statins in endometrial cancer
Abdul Muzhill Hannaan Abdul Hafizz,Reena Rahayu Md Zin,Nor Haslinda Abd Aziz,Nirmala Chandralega Kampan,Mohamad Nasir Shafiee
Molecular Biology Reports. 2020;
[Pubmed]  [Google Scholar] [DOI]
5 Pathophysiological mechanisms of statin-associated myopathies: possible role of the ubiquitin-proteasome system
Amirhossein Sahebkar,Arrigo F.G. Cicero,Paolo Di Giosia,Irene Pomilio,Cosimo Andrea Stamerra,Paolo Giorgini,Claudio Ferri,Stephan Haehling,Maciej Banach,Tannaz Jamialahmadi
Journal of Cachexia, Sarcopenia and Muscle. 2020;
[Pubmed]  [Google Scholar] [DOI]
6 Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins
Kayalvizhi Madhivanan,Swetha Ramadesikan,Wen-Chieh Hsieh,Mariana C Aguilar,Claudia B Hanna,Robert L Bacallao,R Claudio Aguilar
Human Molecular Genetics. 2020;
[Pubmed]  [Google Scholar] [DOI]
7 Influence of the Preparation Method on Some Characteristics of Alginate/Chitosan/Lovastatin Composites
Duc-Thuan Nghiem,Thuy-Chinh Nguyen,Minh-Thanh Do,Thi-Huyen Nguyen,Dai Lam Tran,Tran-Dung Hoang,Van-Quan Le,Quoc-Trung Vu,Duy-Trinh Nguyen,Hoang Thai
Advances in Polymer Technology. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
8 The Incidence of Adverse Drug Reactions in Patients Treated with Statins in the Emirates: A Retrospective Cohort Study
Abdulla Shehab,Akshaya S. Bhagavathula,Asim A. Elnour,Khalid Al-Rasadi,Saif Al-Shamsi
Current Vascular Pharmacology. 2020; 18(2): 193
[Pubmed]  [Google Scholar] [DOI]
9 Pharmacogenetics of Statin-Induced Myotoxicity
Ping Siu Kee,Paul Ken Leong Chin,Martin A. Kennedy,Simran D. S. Maggo
Frontiers in Genetics. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
10 Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers
Alastair Khodabukus,Amulya Kaza,Jason Wang,Neel Prabhu,Richard Goldstein,Vishal S Vaidya,Nenad Bursac
Toxicological Sciences. 2020;
[Pubmed]  [Google Scholar] [DOI]
11

Comparison of Lipid Profile, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy

Mezgebu Legesse Habte,Daniel Seifu Melka,Maria Degef,MKC Menon,Helen Yifter,Teka Obsa Feyisa
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020; Volume 13: 763
[Pubmed]  [Google Scholar] [DOI]
12 Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques: 3-year prevention with the supplementation with Pycnogenol®+Centellicum®
Gianni Belcaro,Maria R. Cesarone,Claudia Scipione,Valeria Scipione,Mark Dugall,Hu Shu,Paula Peterzan,Marcello Corsi,Roberta Luzzi,Morio Hosoi,Beatrice Feragalli,Roberto Cotellese
Minerva Cardioangiologica. 2020; 68(1)
[Pubmed]  [Google Scholar] [DOI]
13 Statins-related peripheral neuropathy among diabetic patients
Mohamed A. Hammad,Syed Azhar Syed Sulaiman,Saleh Alghamdi,Altaf Ali Mangi,Nor Azizah Aziz,Dzul Azri Mohamed Noor
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;
[Pubmed]  [Google Scholar] [DOI]
14 A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Gagan D. Flora,Manasa K. Nayak
Current Pharmaceutical Design. 2019; 25(38): 4063
[Pubmed]  [Google Scholar] [DOI]
15 Natural Antioxidant Anthocyanins—A Hidden Therapeutic Candidate in Metabolic Disorders with Major Focus in Neurodegeneration
Rahat Ullah,Mehtab Khan,Shahid Ali Shah,Kamran Saeed,Myeong Ok Kim
Nutrients. 2019; 11(6): 1195
[Pubmed]  [Google Scholar] [DOI]
16 Conceptual design of hybrid PCSK9 lead inhibitors against coronary artery disease
Ayarivan Puratchikody,Navabshan Irfan,Sakthivel Balasubramaniyan
Biocatalysis and Agricultural Biotechnology. 2019; 17: 427
[Pubmed]  [Google Scholar] [DOI]
17 Comparative evaluation of renal, pleiotropic and myotropic effects of statins in rats
V.G. Zeleniuk,I.I. Zamorskii,O.V. Gerush,T.S. Shchudrova,O.M. Goroshko,A.R. Zeleniuk
Fiziolohichnyi zhurnal. 2019; 65(2): 76
[Pubmed]  [Google Scholar] [DOI]
18 Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase of stability of statins
Ricardo Lorenzoni,Leticia Malgarim Cordenonsi,Samuel Davies,Michelli Barcelos Antonow,Aline Scheinder Medina Diedrich,Cayane Genro Santos,Graciela Schneider Vitalis,Gabriela Garrastazu,Francesca Buttini,Fabio Sonvico,Patrícia Gomes,Renata Platcheck Raffin
Journal of Microencapsulation. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
19 The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors
Hayrettin Ozan Gulcan,Serkan Yigitkan,Ilkay Erdogan Orhan
Letters in Drug Design & Discovery. 2019; 16(10): 1130
[Pubmed]  [Google Scholar] [DOI]
20 The Role of n-3 Long Chain Polyunsaturated Fatty Acids in Cardiovascular Disease Prevention, and Interactions with Statins
Julia Bird,Philip Calder,Manfred Eggersdorfer
Nutrients. 2018; 10(6): 775
[Pubmed]  [Google Scholar] [DOI]
21 Repurposing of statins via inhalation to treat lung inflammatory conditions
Peta Bradbury,Daniela Traini,Alaina J. Ammit,Paul M. Young,Hui Xin Ong
Advanced Drug Delivery Reviews. 2018;
[Pubmed]  [Google Scholar] [DOI]
22 A Brief Drug Class Review: Considerations for Statin Use, Toxicity, and Drug Interactions
James M. Wooten
Southern Medical Journal. 2018; 111(1): 39
[Pubmed]  [Google Scholar] [DOI]
23 Cannabinoids, the Heart of the Matter
Naghum Alfulaij,Franziska Meiners,Justin Michalek,Andrea L. Small-Howard,Helen C. Turner,Alexander J. Stokes
Journal of the American Heart Association. 2018; 7(14)
[Pubmed]  [Google Scholar] [DOI]
24 Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort study
Richard Ofori-Asenso,Jenni Ilomäki,Mark Tacey,Si Si,Andrea J. Curtis,Ella Zomer,J. Simon Bell,Sophia Zoungas,Danny Liew
British Journal of Clinical Pharmacology. 2018;
[Pubmed]  [Google Scholar] [DOI]
25 Statin drugs to reduce breast cancer recurrence and mortality
Colin H. Beckwitt,Adam Brufsky,Zoltán N. Oltvai,Alan Wells
Breast Cancer Research. 2018; 20(1)
[Pubmed]  [Google Scholar] [DOI]
26 Effects of probiotic supplementation on lipid profile of women with rheumatoid arthritis: A randomized placebo-controlled clinical trial
Elnaz Vaghef-Mehrabany,Leila Vaghef-Mehrabany,Mohammad Asghari-Jafarabadi,Aziz Homayouni-Rad,Karim Issazadeh,Beitullah Alipour
Health Promotion Perspectives. 2017; 7(2): 95
[Pubmed]  [Google Scholar] [DOI]
27 Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study
Giulia M. Camerino,Olimpia Musumeci,Elena Conte,Kejla Musaraj,Adriano Fonzino,Emanuele Barca,Marco Marino,Carmelo Rodolico,Domenico Tricarico,Claudia Camerino,Maria R. Carratù,Jean-François Desaphy,Annamaria De Luca,Antonio Toscano,Sabata Pierno
Frontiers in Pharmacology. 2017; 8
[Pubmed]  [Google Scholar] [DOI]
28 A severe myopathy case in aged patient treated with high statin dosage
Canzonieri Elena,De Candia Cristina,Tarascio Salvatore,Giamporcaro Silvia,Lumera Giovanni,Rigano Giuseppe,Incognito Carmela,Privitera Filippo,Guarnaccia Agata,Foti Pietro Valerio,Palmucci Stefano,Gangemi Pietro,Fuccio-Sanzà Giulia,Signorelli Salvatore Santo
Toxicology Reports. 2017; 4: 438
[Pubmed]  [Google Scholar] [DOI]
29 Intranasal pitavastatin attenuates seizures in different experimental models of epilepsy in mice
Muhammad Usama Ashhar,Mohd. Zubair Ahmad,Vikas Jain,Nidhi B. Agarwal,Farhan J. Ahmad,Gaurav K. Jain
Epilepsy & Behavior. 2017; 75: 56
[Pubmed]  [Google Scholar] [DOI]
30 Statins: All you need to know
Sharon Rees
Nurse Prescribing. 2017; 15(5): 230
[Pubmed]  [Google Scholar] [DOI]
31 Icaritin Inhibits Collagen Degradation-Related Factors and Facilitates Collagen Accumulation in Atherosclerotic Lesions: A Potential Action for Plaque Stabilization
Zong-Kang Zhang,Jie Li,De-Xin Yan,Wing-Nang Leung,Bao-Ting Zhang
International Journal of Molecular Sciences. 2016; 17(2): 169
[Pubmed]  [Google Scholar] [DOI]
32 Diagnosis, Prevention and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)
G. B. John Mancini,Steven Baker,Jean Bergeron,David Fitchett,Jiri Frohlich,Jacques Genest,Milan Gupta,Robert A. Hegele,Dominic Ng,Glen J. Pearson,Janet Pope,A. Yashar Tashakkor
Canadian Journal of Cardiology. 2016;
[Pubmed]  [Google Scholar] [DOI]
33 Developmentand Validation of a Questionnaire about Patient Knowledge of Adverse Effects of Statins
Valentina Opancina,Slobodan Jankovic,Gordana Stanic,Miljan Opancina
Acta Facultatis Medicae Naissensis. 2016; 33(4)
[Pubmed]  [Google Scholar] [DOI]
34 Biochemical Changes in Erythrocytes as a Molecular Marker of Cell Damage during Long-Term Simvastatin Treatment
Z. I. Mikashinovich,E. S. Belousova
Bulletin of Experimental Biology and Medicine. 2016; 161(4): 600
[Pubmed]  [Google Scholar] [DOI]
35 Development and Validation of Algorithms to Identify Statin Intolerance in a US Administrative Database
Kathy L. Schulman,Lois E. Lamerato,Mehul R. Dalal,Jennifer Sung,Mehul Jhaveri,Andrew Koren,Usha G. Mallya,JoAnne M. Foody
Value in Health. 2016;
[Pubmed]  [Google Scholar] [DOI]
36 Controversy of oral hypoglycemic agents in type 2 diabetes mellitus: Novel move towards combination therapies
Abhijit A. Ghadge,Aniket A. Kuvalekar
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2016;
[Pubmed]  [Google Scholar] [DOI]
37 Risk identification and possible countermeasures for muscle adverse effects during statin therapy
Paolo Magni,Chiara Macchi,Beatrice Morlotti,Cesare R. Sirtori,Massimiliano Ruscica
European Journal of Internal Medicine. 2015;
[Pubmed]  [Google Scholar] [DOI]
38 Cardiovascular Pharmacogenomics; State of Current Knowledge and Implementation in Practice
Payman Shahabi,Marie-Pierre Dubé
International Journal of Cardiology. 2015;
[Pubmed]  [Google Scholar] [DOI]
39 Doença renal crônica e tratamento em idosos: uma revisão integrativa
Fernanda Guilhermino Magalhães,Rita Maria Monteiro Goulart
Revista Brasileira de Geriatria e Gerontologia. 2015; 18(3): 679
[Pubmed]  [Google Scholar] [DOI]
40 Lovastatin-Mediated Changes in Human Tendon Cells
Maria Kuzma-Kuzniarska,Hannah R. Cornell,Michael C. Moneke,Andrew J. Carr,Philippa A. Hulley
Journal of Cellular Physiology. 2015; 230(10): 2543
[Pubmed]  [Google Scholar] [DOI]
41 Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3–Related Dwarfism
Daniel J. Wendt,Melita Dvorak-Ewell,Sherry Bullens,Florence Lorget,Sean M. Bell,Jeff Peng,Sianna Castillo,Mika Aoyagi-Scharber,Charles A. O’Neill,Pavel Krejci,William R. Wilcox,David L. Rimoin,Stuart Bunting
Journal of Pharmacology and Experimental Therapeutics. 2015; 353(1): 132
[Pubmed]  [Google Scholar] [DOI]
42 Effect of rosuvastatin on hyperuricemic rats and the protective effect on endothelial dysfunction
DILIDAER XILIFU,ABULIZI ABUDULA,NIJIATI REHEMU,LONG ZHAO,XINRONG ZHOU,XIANGYANG ZHANG
Experimental and Therapeutic Medicine. 2014; 8(6): 1683
[Pubmed]  [Google Scholar] [DOI]
43 High-dose rosuvastatin treatment for multifocal stroke in trauma-induced cerebral fat embolism syndrome: A Case Report
Lesta D. Whalen,Sandeep P. Khot,Stephen W. Standage
Pediatric Neurology. 2014;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article